Through a complementation-related approach in yeast, we previously identified the novel gene HEF1 (Human Enhancer of Filamentation 1) as a potential coordinator of cell growth signaling, morphological regulation, and cell cycle control. Sequence analysis indicates HEF1 is one of three members of a docking/adaptor protein family that includes p130Cas and Efs/Sin. Members of this family possess a highly conserved domain structure characterized by an amino-terminal SH3 domain that allows association with focal adhesion kinase (FAK) at focal adhesions, and a central SH2-binding site rich region that allows phosphorylation and association with numerous oncoproteins, including Crk, Abl, Fyn. These observations lead to the idea that HEF1 family proteins function in cell adhesion. More recent data have indicated that HEF1 may also play a role in regulating cell differentiation and apoptosis. The conserved carboxy-terminal domain of HEF1 was shown to encompass a helix-loop-helix (HLH) that confers dimerization with the differentiation control protein, Id2; disruption of this HLH eliminates not only the association with Id2, but also the effector function of this region in the yeast morphology-based assay. The HEF1 protein is post-translationally cleaved at mitosis or during induction of apoptosis into a number of smaller species. The latter are predominantly nuclear-localized, and at least one associates specifically with the mitotic spindle. These and other data suggest that HEF1 may be uniquely suited to directly integrate a large number of cellular control networks responsible for cell-cell contact, cell identity, and cell survival. The current proposal will directly examine this hypothesis, first by characterizing the nature of the HEF1 cleavage products, and then by investigating the role of each HEF1 form and of two novel HEF1-interacting proteins in regulating differentiation and apoptosis, using appropriate model systems. Based on the HEF1 expression pattern, this work should produce considerable insight into cellular signaling networks relevant to cancer in epithelial and hematopoietic cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA063366-05
Application #
2765351
Study Section
Pathology B Study Section (PTHB)
Program Officer
Spalholz, Barbara A
Project Start
1994-06-01
Project End
2003-03-31
Budget Start
1998-06-01
Budget End
1999-03-31
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Institute for Cancer Research
Department
Type
DUNS #
872612445
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Gabbasov, Rashid; Xiao, Fang; Howe, Caitlin G et al. (2018) NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice. Oncogene 37:4854-4870
Bobrov, Egor; Skobeleva, Natalia; Restifo, Diana et al. (2017) Targeted delivery of chemotherapy using HSP90 inhibitor drug conjugates is highly active against pancreatic cancer models. Oncotarget 8:4399-4409
Zhang, Yong-Wei; Nasto, Rochelle E; Jablonski, Sandra A et al. (2017) RNA Interference Screening to Identify Proliferation Determinants in Breast Cancer Cells. Bio Protoc 7:
Gaponova, Anna V; Nikonova, Anna S; Deneka, Alexander et al. (2016) A Novel HSP90 Inhibitor-Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer. Clin Cancer Res 22:5120-5129
Zhang, Y-W; Nasto, R E; Varghese, R et al. (2016) Acquisition of estrogen independence induces TOB1-related mechanisms supporting breast cancer cell proliferation. Oncogene 35:1643-56
Beglyarova, Natalya; Banina, Eugenia; Zhou, Yan et al. (2016) Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3-MYC Interactions as a Target in Pancreatic Cancer. Clin Cancer Res 22:6153-6163
Gabitova, Linara; Restifo, Diana; Gorin, Andrey et al. (2015) Endogenous Sterol Metabolites Regulate Growth of EGFR/KRAS-Dependent Tumors via LXR. Cell Rep 12:1927-38
Arora, Sanjeevani; Yan, Hong; Cho, Iltaeg et al. (2015) Genetic Variants That Predispose to DNA Double-Strand Breaks in Lymphocytes From a Subset of Patients With Familial Colorectal Carcinomas. Gastroenterology 149:1872-1883.e9
Ramirez, Ursula D; Nikonova, Anna S; Liu, Hanqing et al. (2015) Compounds identified by virtual docking to a tetrameric EGFR extracellular domain can modulate Grb2 internalization. BMC Cancer 15:436
Shagisultanova, Elena; Dunbrack Jr, Roland L; Golemis, Erica A (2015) Issues in interpreting the in vivo activity of Aurora-A. Expert Opin Ther Targets 19:187-200

Showing the most recent 10 out of 68 publications